Stocks

Key Takeaways Bristol Myers Squibb’s drug to treat schizophrenia was approved for use by the …

Key Takeaways Accenture shares could remain on watchlists after jumping more than 5% Thursday following …

Key Takeaways Limits on state and local tax (SALT) deductions on federal tax forms could …

Key Takeaways Shares of beauty products maker Estée Lauder climbed 10% on Thursday, posting one …

Key Takeaways Jefferies analysts downgraded Hershey to underperform and lowered their price target. The firm …

Key Takeaways The volatile month for shares of Nvidia continued Thursday, with the stock gaining …

Key Takeaways Southwest Airlines shares surged Thursday as the airline adjusted its third-quarter and full-year …

Key Takeaways Caterpillar shares hit a record high Thursday and are up more than 30% …

Key Takeaways Major U.S. indexes gained at midday Thursday as chip stocks surged, led by …

Key Takeaways Pending home sales rose 0.6% in August, bouncing back slightly from the record …

Key Takeaways Pfizer is withdrawing all of its sickle cell disease drug, Oxbryta, worldwide because …

Key Takeaways Accenture exceeded fourth-quarter revenue forecasts on rising demand for its generative AI services. …

Key Takeaways Shares of electric utility Vistra finished almost 6% higher on Wednesday, securing the …

<img src='https://www.investopedia.com/thmb/znHtd_xLPL3Hwiah2pHNoV-00OI=/filters:no_upscale():max_bytes(150000):strip_icc():format(jpeg)/GettyImages-21603090801-7436ba23171248e4a456620d41f1a60e.jpg' alt=' Justin Sullivan/Getty Images ‘ title=”Jim Cantori “> Justin Sullivan/Getty Images Key Takeaways …